Synaptic vesicle protein 2A as a potential biomarker in synaptopathies-Reference-Cited by-同舟云学术

Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

Published:2019-06 Issue: Volume:97 Page:34-42
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Heurling Kerstin^ORCID,Ashton Nicholas J.,Leuzy Antoine,Zimmer Eduardo R.,Blennow Kaj,Zetterberg Henrik,Eriksson Jonas,Lubberink Mark^ORCID,Schöll Michael^ORCID

Funder

Knut och Alice Wallenberg Foundation

Anna-Lisa and Bror Björnssons Foundation

Magnus Bergvalls Foundation

Swedish Research Council

European Research Council

UK Dementia Research Institute at UCL and Swedish State Support for Clinical Research

CAPES

CNPq

PRONEX

Brazilian National Institute of Science and Technology in Excitotoxicity and Neuroprotection

the Knut och Alice Wallenberg Foundation

Swedish Alzheimer Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference95 articles.

1. A review of beta-amyloid neuroimaging in Alzheimer's disease;Adlard;Front. Neurosci.,2014

2. Cell Communication, in: Essential Cell Biology: An Introduction to the Molecular Biology of the Cell;Alberts,1997

3. Medicinal Chemistry strategies for PET tracer discovery;Andrés;Drug Discov. Today Technol.,2017

4. Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H;Bahri;Alzheimers Dement.,2017

5. Differential expression of synaptic vesicle protein 2 (SV2) isoforms;Bajjalieh;J. Neurosci.,1994

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders;BMC Psychiatry;2024-06-19

2. Evaluation of [11C]UCB-A positron emission tomography in human brains;EJNMMI Research;2024-06-17

3. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment;Alzheimer's & Dementia;2024-04-18

4. Current status of PET tracers for the early diagnosis of Alzheimer's disease;TrAC Trends in Analytical Chemistry;2024-03

5. Tracing synaptic loss in Alzheimer's brain with SV2A PET‐tracer UCB‐J;Alzheimer's & Dementia;2024-02-16